APOE gene related symptoms and diseases

All the information presented here about the APOE gene and its related diseases, symptoms, and test panels has been aggregated from the following public sources: OMIM,HGNC,NCBIGENE,ORPHANET, Mendelian Rare Disease Search Engine.

Top 5 symptoms and clinical features associated to APOE gene

Symptoms // Phenotype % Cases
Dementia Common - Between 50% and 80% cases
Edema Common - Between 50% and 80% cases
Neurofibrillary tangles Uncommon - Between 30% and 50% cases
Alzheimer disease Uncommon - Between 30% and 50% cases
Stroke Uncommon - Between 30% and 50% cases

Other less frequent symptoms and clinical features

Patients with APOE gene alterations may also develop some of the following symptoms and phenotypes:
  • Not very common - Between 30% and 50% cases

  • Hypertension
  • Thrombocytopenia
  • Senile plaques
  • Parkinsonism
  • Intellectual disability
  • Seizures
  • Hepatomegaly
  • Rarely - Less than 30% cases

  • Splenomegaly

And 291 more phenotypes, you can get all of them using our tools for rare diseases.

Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Rare diseases associated to APOE gene

Here you will find a list of rare diseases related to the APOE. You can also use our tool to get a more accurate diagnosis based on your current symptoms.


ALZHEIMER DISEASE; AD


Alternate names

ALZHEIMER DISEASE; AD Is also known as presenile and senile dementia

Description

Alzheimer disease is the most common form of progressive dementia in the elderly. It is a neurodegenerative disorder characterized by the neuropathologic findings of intracellular neurofibrillary tangles (NFT) and extracellular amyloid plaques that accumulate in vulnerable brain regions (Sennvik et al., 2000). Terry and Davies (1980) pointed out that the 'presenile' form, with onset before age 65, is identical to the most common form of late-onset or 'senile' dementia, and suggested the term 'senile dementia of the Alzheimer type' (SDAT).Haines (1991) reviewed the genetics of AD. Selkoe (1996) reviewed the pathophysiology, chromosomal loci, and pathogenetic mechanisms of Alzheimer disease. Theuns and Van Broeckhoven (2000) reviewed the transcriptional regulation of the genes involved in Alzheimer disease. Genetic Heterogeneity of Alzheimer DiseaseAlzheimer disease is a genetically heterogeneous disorder. See also AD2 (OMIM ), associated with the APOE*4 allele (OMIM ) on chromosome 19; AD3 (OMIM ), caused by mutation in the presenilin-1 gene (PSEN1 ) on 14q; and AD4 (OMIM ), caused by mutation in the PSEN2 gene (OMIM ) on 1q31.There is evidence for additional AD loci on other chromosomes; see AD5 (OMIM ) on 12p11, AD6 (OMIM ) on 10q24, AD7 (OMIM ) on 10p13, AD8 (OMIM ) on 20p, AD9 (OMIM ), associated with variation in the ABCA7 gene (OMIM ) on 19p13, AD10 (OMIM ) on 7q36, AD11 (OMIM ) on 9q22, AD12 (OMIM ) on 8p12-q22, AD13 (OMIM ) on 1q21, AD14 (OMIM ) on 1q25, AD15 (OMIM ) on 3q22-q24, AD16 (OMIM ) on Xq21.3, AD17 (OMIM ) on 6p21.2, and AD18 (OMIM ), associated with variation in the ADAM10 gene (OMIM ) on 15q21.Evidence also suggests that mitochondrial DNA polymorphisms may be risk factors in Alzheimer disease (OMIM ).Finally, there have been associations between AD and various polymorphisms in other genes, including alpha-2-macroglobulin (A2M; {103950.0005}), low density lipoprotein-related protein-1 (LRP1 ), the transferrin gene (TF ), the hemochromatosis gene (HFE ), the NOS3 gene (OMIM ), the vascular endothelial growth factor gene (VEGF ), the ABCA2 gene (OMIM ), and the TNF gene (OMIM ) (see MOLECULAR GENETICS).

Most common symptoms of ALZHEIMER DISEASE; AD

  • Intellectual disability
  • Seizures
  • Spasticity
  • Cognitive impairment
  • Edema


More info about ALZHEIMER DISEASE; AD

SOURCES: OMIM

MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1


Alternate names

MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1 Is also known as maculopathy, age-related, 1

Description

Age-related macular degeneration (ARMD) is a progressive degeneration of photoreceptors and underlying retinal pigment epithelium (RPE) cells in the macula region of the retina. It is a highly prevalent disease and a major cause of blindness in the Western world. Drusen, pale excrescences of variable size, and other deposits accumulate below the RPE on the Bruch membrane; clinical and histopathologic investigations have shown that these extracellular deposits are the hallmark of early ARMD. As ARMD advances, areas of geographic atrophy of the RPE can cause visual loss, or choroidal neovascularization can occur to cause wet, or exudative, ARMD with accompanying central visual loss (summary by De et al., 2007). Genetic Heterogeneity of Age-Related Macular DegenerationARMD2 (OMIM ) is associated with mutation in the ABCR gene (OMIM ) on chromosome 1p, and ARMD3 (OMIM ) is caused by mutation in the FBLN5 gene (OMIM ) on chromosome 14q31. Up to 50% of the attributable risk of age-related macular degeneration (ARMD4 ) appears to be explained by a polymorphism in the CFH gene ({134370.0008}). ARMD5 (OMIM ) and ARMD6 (OMIM ) are associated with mutation in the ERCC6 (OMIM ) and RAX2 (OMIM ) genes, respectively. ARMD7 (OMIM ) and ARMD8 (OMIM ), which both represent susceptibility linked to chromosome 10q26, are associated with single-nucleotide polymorphisms in the HTRA1 (OMIM ) and ARMS2 (OMIM ) genes, respectively. ARMD9 (OMIM ) is associated with single-nucleotide polymorphisms in the C3 gene (OMIM ). ARMD10 (OMIM ) maps to chromosome 9q32 and may be associated with a polymorphism in the TLR4 gene (OMIM ). ARMD11 (OMIM ) is association with variation in the CST3 gene (OMIM ); ARMD12 (OMIM ) with variation in the CX3CR1 gene (OMIM ); and ARMD13 (OMIM ) with variation in the CFI gene (OMIM ). ARMD14 (OMIM ) is associated with variation in or near the C2 (OMIM ) and CFB (OMIM ) genes on chromosome 6p21. ARMD15 (OMIM ) is associated with variation in the C9 gene (OMIM ). There is evidence for a form of ARMD caused by mutation in the mitochondrial gene MTTL1 (OMIM ).A haplotype carrying deletion of the complement factor H-related genes CFHR1 (OMIM ) and CFHR3 (OMIM ) is also associated with reduced risk of ARMD.Lotery and Trump (2007) reviewed the molecular biology of age-related macular degeneration and tabulated the genes associated with ARMD, including those with only positive findings versus genes for which conflicting results have been found.

Most common symptoms of MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1

  • Cataract
  • Visual impairment
  • Hypertension
  • Blindness
  • Visual loss


More info about MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1

SOURCES: MESH OMIM

ALZHEIMER DISEASE 2; AD2


Alternate names

ALZHEIMER DISEASE 2; AD2 Is also known as alzheimer disease associated with apoe4, alzheimer disease 2, late-onset

Description

A degenerative disease of the brain characterized by the insidious onset of dementia. Impairment of memory, judgment, attention span, and problem solving skills are followed by severe apraxia and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of senile plaques, neurofibrillary tangles, and neuropil threads. [HPO:probinson]

Most common symptoms of ALZHEIMER DISEASE 2; AD2

  • Hypertension
  • Dementia
  • Diabetes mellitus
  • Stroke
  • Parkinsonism


More info about ALZHEIMER DISEASE 2; AD2

SOURCES: OMIM MESH

ALZHEIMER DISEASE 4


Alternate names

ALZHEIMER DISEASE 4 Is also known as ad4, alzheimer disease, familial, 4

Description

Alzheimer's disease with an early onset (starts before the age of 65). It is caused by mutations in the PSEN2 gene.

Most common symptoms of ALZHEIMER DISEASE 4

  • Seizures
  • Tremor
  • Depressivity
  • Dementia
  • Myoclonus


More info about ALZHEIMER DISEASE 4

SOURCES: MESH OMIM

DOWN SYNDROME


Alternate names

DOWN SYNDROME Is also known as trisomy 21

Description

Down syndrome is a chromosomal abnormality caused by the presence of a third (partial or total) copy of chromosome 21 and that is characterized by variable intellectual disability, muscular hypotonia, and joint laxity, often associated with a characteristic facial dysmorphism and various anomalies such as cardiac, gastrointestinal, or endocrine defects.

Most common symptoms of DOWN SYNDROME

  • Intellectual disability
  • Global developmental delay
  • Short stature
  • Generalized hypotonia
  • Hearing impairment


More info about DOWN SYNDROME

SOURCES: ORPHANET MESH OMIM

HYPERLIPOPROTEINEMIA TYPE 3


Alternate names

HYPERLIPOPROTEINEMIA TYPE 3 Is also known as dyslipidemia type 3, apolipoprotein e, deficiency or defect of, familial hypercholesterolemia with hyperlipemia, broad-betalipoproteinemia, hlp type 3, hyperlipidemia type 3, familial dysbetalipoproteinemia, familial hyperlipoproteinemia type 3, dysbetalipoprotei

Description

Hyperlipoproteinemia (HLP) type 3 is a rare combined hyperlipidemia characterized by high levels of cholesterol and triglycerides, transported by intermediate density lipoproteins (IDLs), and a high risk of premature atherosclerosis and cardiovascular disease.

Most common symptoms of HYPERLIPOPROTEINEMIA TYPE 3

  • Hepatomegaly
  • Obesity
  • Diabetes mellitus
  • Hypothyroidism
  • Hepatic steatosis


More info about HYPERLIPOPROTEINEMIA TYPE 3

SOURCES: ORPHANET OMIM

SEA-BLUE HISTIOCYTOSIS


Alternate names

SEA-BLUE HISTIOCYTOSIS Is also known as sea-blue histiocytosis, histiocytosis, sea-blue

Description

A congenital disease caused by an inborn error involving APOLIPOPROTEINS E leading to abnormal LIPID METABOLISM and the accumulation of GLYCOSPHINGOLIPIDS, particularly SPHINGOMYELINS in the HISTIOCYTES. This disorder is characterized by SPLENOMEGALY and the sea-blue histiocytes in the spleen and bone marrow after May Grunwald staining.

Most common symptoms of SEA-BLUE HISTIOCYTOSIS

  • Seizures
  • Ataxia
  • Peripheral neuropathy
  • Hepatomegaly
  • Gait disturbance


More info about SEA-BLUE HISTIOCYTOSIS

SOURCES: OMIM MESH ORPHANET

WILSON DISEASE


Alternate names

WILSON DISEASE Is also known as wd, hepatolenticular degeneration, wnd

Description

Wilson disease is a very rare inherited multisystemic disease presenting non-specific neurological, hepatic, psychiatric or osseo-muscular manifestations due to excessive copper deposition in the body.

Most common symptoms of WILSON DISEASE

  • Intellectual disability
  • Growth delay
  • Neoplasm
  • Failure to thrive
  • Spasticity


More info about WILSON DISEASE

SOURCES: MESH OMIM ORPHANET

LIPOPROTEIN GLOMERULOPATHY


Alternate names

LIPOPROTEIN GLOMERULOPATHY Is also known as lpg

Description

Lipoprotein glomerulopathy is an uncommon kidney disease characterized by proteinuria, progressive kidney failure, and distinctive lipoprotein thrombi in glomerular capillaries (Saito et al., 2006). It mainly affects people of Japanese and Chinese origin; in these populations, it is associated with mutations in the gene that encodes apolipoprotein E (APOE ). The disorder had rarely been described in Caucasians.

Most common symptoms of LIPOPROTEIN GLOMERULOPATHY

  • Edema
  • Renal insufficiency
  • Carcinoma
  • Proteinuria
  • Abnormality of the kidney


More info about LIPOPROTEIN GLOMERULOPATHY

SOURCES: ORPHANET OMIM MESH


Potential gene panels for APOE gene

ADmark® ApoE Genotype Analysis and Interpretation (Symptomatic) Panel

United States.

By Athena Diagnostics Inc

This panel specifically test the APOE gene.

More info about this panel

Dementia Panel

United States.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University Dementia that also includes the following genes: SORL1 TARDBP VCP FIG4 OPTN TREM2 CSF1R CHMP2B DCTN1 C9orf72

More info about this panel

Apolipoprotein E (APOE) Genotype Panel

United States.

By Molecular Diagnostics Laboratory University of Toledo Medical Center

This panel specifically test the APOE gene.

More info about this panel

APOE Panel

Germany.

By Institute for Human Genetics University Clinic Freiburg

This panel specifically test the APOE gene.

More info about this panel

Alzheimer Disease Risk Factor (APOE) Panel

Brazil.

By GENE Núcleo de Genética Médica de Minas Gerais

This panel specifically test the APOE gene.

More info about this panel

Cardiovascular Disease Risk Factor (Apolipoprotein E) Panel

United Kingdom.

By Sheffield Diagnostic Genetics Service Sheffield Children's NHS Foundation Trust

This panel specifically test the APOE gene.

More info about this panel

Dyslipidemia NGS panel (29 genes), Sequence & CNV analysis Panel

Netherlands.

By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam Dyslipidemia NGS panel (29 genes), Sequence & CNV analysis that also includes the following genes: SAR1B SLCO1B1 ABCG5 ABCG8 LMF1 SCARB1 APOA5 LDLRAP1 CETP PCSK9

More info about this panel

APOE. Genotyping of the alleles E2, E3 and E4 Panel

Spain.

By Instituto de Medicina Genomica Instituto de Medicina Genomica

This panel specifically test the APOE gene.

More info about this panel

APOE, APP, PSEN1, PSEN2. NextGeneDx.Complete sequencing by NGS Panel

Spain.

By Instituto de Medicina Genomica Instituto de Medicina Genomica APOE, APP, PSEN1, PSEN2. NextGeneDx.Complete sequencing by NGS that also includes the following genes: APOE APP PSEN1 PSEN2

More info about this panel

Alzheimer disease type 2 (APOE gene, alleles E2, E3 and E4) Panel

Portugal.

By CGC Genetics

This panel specifically test the APOE gene.

More info about this panel

Thrombophilia (APOE genotyping) Panel

Portugal.

By CGC Genetics

This panel specifically test the APOE gene.

More info about this panel

Apolipoprotein E deficiency (sequence analysis of APOE gene) Panel

Portugal.

By CGC Genetics

This panel specifically test the APOE gene.

More info about this panel

Alzheimer disease type 2 (APOE gene, alleles E2, E3 and E4) Panel

Portugal.

By CGC Genetics

This panel specifically test the APOE gene.

More info about this panel

Alzheimer disease (NGS panel for 8 genes) Panel

Portugal.

By CGC Genetics Alzheimer disease (NGS panel for 8 genes) that also includes the following genes: SNCA SNCB SORL1 APOE APP PRNP PSEN1 PSEN2

More info about this panel

Hereditary dementias (NGS panel for 28 genes) Panel

Portugal.

By CGC Genetics Hereditary dementias (NGS panel for 28 genes) that also includes the following genes: SNCA SNCB SORL1 TARDBP TIMM8A TUBA4A TYROBP UBQLN2 VCP CHCHD10

More info about this panel

Alzheimer Disease Risk Factor (APOE Genotype) Panel

India.

By Institute of Medical Genetics and Genomics Sir Ganga Ram Hospital

This panel specifically test the APOE gene.

More info about this panel

Alzheimer disease Panel

Germany.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders

This panel specifically test the APOE gene.

More info about this panel

Lipoprotein glomerulopathy Panel

Germany.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders

This panel specifically test the APOE gene.

More info about this panel

Apolipoprotein E (APOE) Genotype Panel

Germany.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders

This panel specifically test the APOE gene.

More info about this panel

Chylomicronemia Panel

Germany.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders Chylomicronemia that also includes the following genes: APOA5 GPIHBP1 APOC2 APOE

More info about this panel

Comprehensive Cardiology Sequencing Panel with CNV Detection Panel

United States.

By PreventionGenetics PreventionGenetics Comprehensive Cardiology Sequencing Panel with CNV Detection that also includes the following genes: RYR1 RYR2 SCN1B SCN2B SCN4B SCN5A SCO2 SGCD SGCG BRAF

More info about this panel

Alzheimer Disease Risk Factor (APOE Genotype) Panel

Germany.

By MGZ Medical Genetics Center

This panel specifically test the APOE gene.

More info about this panel

Cardiovascular Disease Risk Factor (Apolipoprotein E) Panel

Germany.

By MGZ Medical Genetics Center

This panel specifically test the APOE gene.

More info about this panel

Neurogenetic Disorders - panels Panel

Germany.

By MGZ Medical Genetics Center Neurogenetic Disorders - panels that also includes the following genes: BCS1L RTN2 RYR1 SACS SCN1A SCN1B SCN2A SCN8A SCO1 SCO2

More info about this panel

Cardiovascular Disease Risk Factor (Apolipoprotein E) Panel

Germany.

By Bioscientia GmbH Center for Human Genetics

This panel specifically test the APOE gene.

More info about this panel

Cardiovascular Disease Risk Factor (Apolipoprotein E) Panel

Czech Republic.

By DNA Diagnostics Laboratory University Hospital Ostrava

This panel specifically test the APOE gene.

More info about this panel

Apolipoprotein E deficiency Panel

Germany.

By Centogene AG - the Rare Disease Company

This panel specifically test the APOE gene.

More info about this panel

Alzheimer dementia and dementia panel Panel

Germany.

By Centogene AG - the Rare Disease Company Alzheimer dementia and dementia panel that also includes the following genes: SORL1 TREM2 APOE APP PRNP PSEN1 PSEN2

More info about this panel

AllNeuro panel Panel

Germany.

By Centogene AG - the Rare Disease Company AllNeuro panel that also includes the following genes: BCS1L ROR2 RPL10 BDNF RPS6KA3 RTN2 RYR1 SACS BIN1 SBF1

More info about this panel

Lipoprotein glomerulopathy Panel

Germany.

By Centogene AG - the Rare Disease Company

This panel specifically test the APOE gene.

More info about this panel

Alzheimer's disease Panel Panel

Germany.

By CeGaT GmbH Alzheimer's disease Panel that also includes the following genes: TBP VPS35 MARK4 NLGN1 CD33 TOMM40 ABCA7 APOE APP PSEN1

More info about this panel

Dementia all Panel Panel

Germany.

By CeGaT GmbH Dementia all Panel that also includes the following genes: ATXN2 SQSTM1 TARDBP TBK1 TBP TUBA4A UBQLN2 VCP VPS35 MARK4

More info about this panel

Single gene testing APOE Panel

Germany.

By CeGaT GmbH

This panel specifically test the APOE gene.

More info about this panel

Alzheimer Disease Risk Factor (APOE Genotype) Panel

Israel.

By GGA - Galil Genetic Analysis

This panel specifically test the APOE gene.

More info about this panel

Cardiovascular Disease Risk Factor (Apolipoprotein E) Panel

Germany.

By MVZ Dortmund Dr. Eberhard & Partner

This panel specifically test the APOE gene.

More info about this panel

Hyperlipoproteinemia, type 3 Panel

Estonia.

By Asper Biogene Asper Biogene LLC

This panel specifically test the APOE gene.

More info about this panel

Cardiovascular Diseases_General Panel Panel

Spain.

By Health in Code Cardiovascular Diseases_General Panel that also includes the following genes: RIT1 MRPL3 RRAS RYR1 RYR2 SAR1B BLK SCN10A SCN1B SCN2B

More info about this panel

Familialhypercholesterolemia Basic Panel Panel

Spain.

By Health in Code Familialhypercholesterolemia Basic Panel that also includes the following genes: SLCO1B1 LDLRAP1 PCSK9 APOE LDLR

More info about this panel

Dyslipidemias / Early atherosclerosis Panel

Spain.

By Health in Code Dyslipidemias / Early atherosclerosis that also includes the following genes: RYR1 SAR1B BLK SLCO1B1 SLC22A8 SLC2A2 HNF1A HNF1B KLF11 WFS1

More info about this panel

Primary familial hypertriglyceridemias Panel

Spain.

By Health in Code Primary familial hypertriglyceridemias that also includes the following genes: LMF1 PCDH15 TRIB1 APOA5 GPIHBP1 SLC25A40 PNPLA2 GPD1 APOC2 APOC3

More info about this panel

Familialhypercholesterolemia Extended Panel Panel

Spain.

By Health in Code Familialhypercholesterolemia Extended Panel that also includes the following genes: RYR1 SLCO1B1 SLC22A8 ABCG5 ABCG8 LDLRAP1 CH25H PCSK9 CPT2 COQ2

More info about this panel

Familial Hypercholesterolaemia Genetic Screen Panel

Australia.

By Cardiovascular Genetics Laboratory PathWest Laboratory Medicine WA Familial Hypercholesterolaemia Genetic Screen that also includes the following genes: ABCG5 ABCG8 LDLRAP1 PCSK9 STAP1 APOE LDLR LIPA

More info about this panel

Hypertriglyceridaemia genetic screen Panel

Australia.

By Cardiovascular Genetics Laboratory PathWest Laboratory Medicine WA Hypertriglyceridaemia genetic screen that also includes the following genes: LMF1 APOA5 GPIHBP1 APOC2 APOE

More info about this panel

Test for Alzheimer Disease Risk Factor (APOE Genotype) Panel

Spain.

By Secugen SL

This panel specifically test the APOE gene.

More info about this panel

Apolipoprotein E deficiency Panel

Austria.

By Praxis fuer Humangenetik Wien

This panel specifically test the APOE gene.

More info about this panel

Apolipoprotein E Genotyping Panel

Singapore.

By Molecular Diagnosis Centre National University Hospital

This panel specifically test the APOE gene.

More info about this panel

Apolipoprotein E deficiency Panel

Slovakia.

By MedGene

This panel specifically test the APOE gene.

More info about this panel

Alzheimer: Apo-E, PSEN1, PSEN2, A2M and APP genes sequence analysis (select exons) Panel

Spain.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases Alzheimer: Apo-E, PSEN1, PSEN2, A2M and APP genes sequence analysis (select exons) that also includes the following genes: APOE APP A2M PSEN1 PSEN2

More info about this panel

Alzheimer: Apo-E, PSEN1, PSEN2, APP, A2M and MAPT genes sequence analysis (select exons) Panel

Spain.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases Alzheimer: Apo-E, PSEN1, PSEN2, APP, A2M and MAPT genes sequence analysis (select exons) that also includes the following genes: APOE APP MAPT A2M PSEN1 PSEN2

More info about this panel

APOE: ApoE gene genotyping Panel

Spain.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases

This panel specifically test the APOE gene.

More info about this panel

Cardiac Medication Metabolism Panel

United States.

By Molecular Diagnostics and Toxicology Laboratory Cardiac Medication Metabolism that also includes the following genes: CYP2C19 CYP2C9 CYP2D6 F2 F5 APOE MTHFR

More info about this panel

Comprehensive Medication Metabolism Panel

United States.

By Molecular Diagnostics and Toxicology Laboratory Comprehensive Medication Metabolism that also includes the following genes: CYP2C19 CYP2C9 CYP2D6 F2 F5 APOE MTHFR

More info about this panel

Expanded Comprehensive Medication Metabolism Panel

United States.

By Molecular Diagnostics and Toxicology Laboratory Expanded Comprehensive Medication Metabolism that also includes the following genes: CYP2C19 CYP2C9 CYP2D6 F2 F5 APOE MTHFR

More info about this panel

Parkinson-Alzheimer-Dementia NGS Panel Panel

United States.

By Fulgent Genetics Fulgent Genetics Parkinson-Alzheimer-Dementia NGS Panel that also includes the following genes: SLC6A3 SNCA SNCB TAF1 TH TYROBP UCHL1 VPS35 FBXO7 AAAS

More info about this panel

APOE Panel

United States.

By Fulgent Genetics Fulgent Genetics

This panel specifically test the APOE gene.

More info about this panel

APOE genotype Panel

Argentina.

By IBC Instituto de Bioquimica Clinica SRL IBC Instituto de Bioquimica Clinica SRL

This panel specifically test the APOE gene.

More info about this panel

KidneySeq - 264 Genes Panel

United States.

By Iowa Institute of Human Genetics University of Iowa KidneySeq - 264 Genes that also includes the following genes: ROBO2 CNNM2 SALL1 ATXN10 SCNN1A SCNN1B SCNN1G SDCCAG8 BMP4 SEMA3E

More info about this panel

Dementia Panel Panel

Finland.

By Blueprint Genetics Dementia Panel that also includes the following genes: SNCA SORL1 TARDBP TUBA4A UBE3A UBQLN2 VCP TREM2 RNF216 CSF1R

More info about this panel

Hyperlipidemia Panel Panel

Finland.

By Blueprint Genetics Hyperlipidemia Panel that also includes the following genes: ABCG5 ABCG8 LMF1 APOA5 LDLRAP1 CREB3L3 PCSK9 GPIHBP1 ALMS1 APOC2

More info about this panel

Genetic Study of Familial Hypercholesterolemia Panel

Portugal.

By HeartGenetics, Genetics and Biotechnology, SA Genetic Study of Familial Hypercholesterolemia that also includes the following genes: LDLRAP1 PCSK9 STAP1 APOE LDLR

More info about this panel

Early-onset autosomal dominant Alzheimer disease Panel

Spain.

By Bioarray

This panel specifically test the APOE gene.

More info about this panel

APOE Panel

Brazil.

By Genomic Engenharia Molecular

This panel specifically test the APOE gene.

More info about this panel

HYPERLIPOPROTEINEMIA TYPE 3 Panel

Spain.

By Laboratorio de Genetica Clinica SL

This panel specifically test the APOE gene.

More info about this panel

DEMENTIA & ALZHEIMER: NGS PANEL Panel

Spain.

By Laboratorio de Genetica Clinica SL DEMENTIA & ALZHEIMER: NGS PANEL that also includes the following genes: SORL1 TARDBP VCP TREM2 CSF1R CHMP2B FUS GRN APOE ITM2B

More info about this panel

APOE genotyping Panel

United States.

By Alpha Genomix Laboratories

This panel specifically test the APOE gene.

More info about this panel

Major Hypertriglyceridemia, Panel Massive Sequencing (NGS) 7 Genes Panel

Spain.

By Reference Laboratory Genetics Major Hypertriglyceridemia, Panel Massive Sequencing (NGS) 7 Genes that also includes the following genes: LMF1 APOA5 LIPI GPIHBP1 APOC2 APOE

More info about this panel

Alzheimer Disease, Panel Massive Sequencing (NGS) 8 Genes Panel

Spain.

By Reference Laboratory Genetics Alzheimer Disease, Panel Massive Sequencing (NGS) 8 Genes that also includes the following genes: C9orf72 GRN APOE APP MAPT A2M PSEN1 PSEN2

More info about this panel

Familial Alzheimer Disease Panel

Germany.

By Labor Dr. Wisplinghoff Familial Alzheimer Disease that also includes the following genes: APOE APP PSEN1

More info about this panel

Apolipoprotein E Genotype Panel

United States.

By True Health Diagnostics

This panel specifically test the APOE gene.

More info about this panel


If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SMARCB1 STK3 COPB2 BPGM

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more